PA
JNP

Perceptive Advisors’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Perceptive Advisors’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,736
Closed -$20K – 189
2015
Q3 		$20K Sell
1,736
-43,164
-96% -$477K ﹤0.01% 152
2015
Q2 		$411K Buy
+44,900
New +$339K 0.02% 134

Other funds holding JNP

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Perceptive Advisors's JNP Position: Q4 2015 in Review

Perceptive Advisors sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q4 2015, closing a stake of 1,736 shares — an estimated $20K sold.

Perceptive Advisors first reported a position in JNP in Q2 2015 and held it in 2 quarters. The position peaked at $411K in Q2 2015. 54 funds tracked by Wall St. Rank hold JNP as of Q4 2015.

  • Perceptive Advisors reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Perceptive Advisors sold 1,736 Juniper Pharmaceuticals, Inc. Common Stock shares in Q4 2015, an estimated $20K.
  • Perceptive Advisors first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q2 2015 and held it in 2 quarters.
  • Perceptive Advisors's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $411K in Q2 2015.
  • 54 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q4 2015.

Based on Perceptive Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.